Results 101 to 110 of about 446,414 (163)

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

, 2012
Daniel L Chan, David L Morris, Archana Rao, Terence C ChuaHepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, and the St George Clinical School, University of New South Wales, St George Hospital, Kogarah, NSW, AustraliaPurpose: To ...
Rao A, Chan DL, Chua TC, Morris DL
core  

State-of-the-Art Therapy in Peritoneal Carcinomatosis Management

Onco
This paper reviews the surgical management of peritoneal carcinomatosis as new surgical methods have been developed within the past few decades. Traditional methods included cytoreductive surgery with hyperthermic intraperitoneal chemotherapy; however, a
Elbek Fozilov, Anthony Weng, Snigdha Kanadibhotla, Nina D. Kosciuszek, Zhaosheng Jin, Sherif R. Abdel-Misih   +5 more
doaj   +1 more source

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case series

Asian Journal of Medical Sciences
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment for advanced abdominopelvic malignancies with peritoneal carcinomatosis. Cytoreductive surgery (CRS) with HIPEC offers hope by increasing the survival rates of these cancers ...
Aswini Lakshminarasimhan , Rajasekar Radhakrishnan , Gowtham Selvarasu   +2 more
doaj   +1 more source

Intraperitoneal Chemotherapy Strategies in Pancreatic Ductal Adenocarcinoma: A Systematic Review of Hyperthermic Intraperitoneal Chemotherapy, Normothermic Intraperitoneal Chemotherapy, and Pressurized Intraperitoneal Aerosol Chemotherapy

Background: Peritoneal metastasis represents an aggressive disease pattern in pancreatic ductal adenocarcinoma (PDAC), traditionally associated with poor survival and limited therapeutic options.
Hani M. Babiker, Umair Majeed, Kamatham, Saivaishnavi, Dina Elantably, O\u2019Donnell, Conor D., Babiker, Hani M., Oluwatayo Adeoye, Nency Ganatra, Saivaishnavi Kamatham, Adeoye, Oluwatayo, Abdelhakeem, Ahmed, Majeed, Umair, Elantably, Dina, Jain, Pragya, Ahmed Abdelhakeem, Ganatra, Nency, Pragya Jain, Conor D. O’Donnell   +17 more
core   +1 more source

Standardizing Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Treatment: Navigating Complexities and Charting the Path Forward

The incorporation of hyperthermic intraperitoneal chemotherapy (HIPEC) into the treatment landscape for ovarian cancer has invoked a spectrum of emotions, ranging from enthusiastic anticipation to cautious skepticism ...
Segura-Sampedro, Juan José, Cascales-Campos, Pedro   +1 more
core   +2 more sources

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study

Pleura and Peritoneum
This explorative porcine study investigated the immediate postoperative response of inflammatory protein markers and ischemic metabolites in peritoneal abdominal wall tissue during and after hyperthermic intraperitoneal chemotherapy (HIPEC) assessed by ...
Petersen Elisabeth Krogsgaard, Bue Mats, Harlev Christina, Jørgensen Andrea René, Hanberg Pelle, Petersen Lone Kjeld, Stilling Maiken   +6 more
doaj   +1 more source

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases

, 2013
Aims and background The prognosis of peritoneal metastases from colorectal cancer has recently improved with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Serena Bonomi, Domenico Iusco, Salvatore Virzì, Antonio Grassi, Marcello Deraco, Dario Baratti, Shigeki Kusamura   +6 more
core   +1 more source

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC

Pleura and Peritoneum
To evaluate the implementation, compliance, and impact of the enhanced recovery after surgery (ERAS) protocol on perioperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for Stage ...
Somashekhar S. P., Rohit Kumar C., Fernandes Aaron, Ahuja Vijay, Aggarwal Kushal, Shanbhag Esha, Ashwin K. R.   +6 more
doaj   +1 more source

Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.

, 2008
Peritoneal carcinomatosis, the second most common cause of death among patients with colorectal carcinoma, may be managed with cytoreductive surgery and adjuvant intraoperative peritoneal hyperthermic chemotherapy (IHPC). We present the case of a 35-year-
Smaldone, Marc C, Tomaszewski, Jeffrey J, Benoit, Ronald M   +2 more
core   +1 more source